Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab in Advanced or Metastatic Penile Cancer
NCT03391479Phase 2Active, not recruiting
- Sponsor
- University Health Network
- Start
- Aug 2018
- Primary completion
- Dec 2026
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avelumab in penile cancer, sponsored by University Health Network. Started Aug 2018; status: active, not recruiting.
02
Drugs
avelumab
03
Conditions
penile cancer
Beyond the preview
Go deeper on NCT03391479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03391479.